Health Trials

Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy

1

Review clinical trials related to Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment

Evaluating the efficacy and safety of Neoantigen Personalized Cancer Vaccine deepGeneAI-001 in combination with Sintilimab in the treatment of Gastrointestinal Solid Tumors

Participants needed: 40
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Ruijin HospitalUpdated: Jul 16, 2025Locations: 1
Eligibility criteria

Voluntarily signs the informed consent form, and has good compliance. [+4]

ECOG performance status of 0 or 1. [+37]

Read more